A strain of gluconacetobacter diazotrophicus (Gd) characterised by the presence of at least one nucleic acid sequence selected from SEQ ID NOS 1-10 or variants or paralogues thereof and/or the presence of a single plasmid of about 17566 bp in size. Such strains, exemplified by IMI504853, are useful in agriculture, in particular as they are able to colonise plants intracellularly.
|
20. A strain of gluconacetobacter diazotrophicus (Gd) deposited with CABI in the United Kingdom under the Budapest Treaty with deposit accession number IMI 504958.
1. A strain of gluconacetobacter diazotrophicus (Gd) comprising nucleic acid encoding one or more expression products encoded by SEQ ID NOS 1 to 10 and a plasmid that is less than 27455 bp in size.
2. The strain of Gd according to
3. The strain of Gd according to
4. The strain of Gd according to
5. The strain of Gd according to
10. The strain of Gd according to
12. A composition comprising the strain of Gd according to
13. The composition according to
14. A seed having a coating thereon, wherein the coating comprises the strain of Gd according to
16. The plant or seed according to
17. A method for producing a plant product, the method comprising growing the plant or seed according to
18. A method for enhancing the nitrogen-fixing ability of a plant, said method comprising applying the strain of Gd according to
19. The method of
|
|||||||||||||||||||||||||||||||||||||||
The present invention relates to novel microorganisms, specifically novel strains of the nitrogen-fixing bacteria Gluconacetobacter diazotrophicus (Gd), and their use in agriculture, including agriculturally acceptable compositions containing these microorganisms. The strains have good utility in agriculture, in terms of their ability to colonise plant cells intracellularly, giving rise to particularly effective nitrogen fixation. Kits for identification and monitoring of the use of these strains form the subject of a co-pending application.
Gluconacetobacter diazotrophicus (Gd) has been well studied for its nitrogen fixing and plant growth promoting activities as reviewed in Eskin et al. International Journal of Agronomy (2014):1-13. Certain strains of Gd however have been shown to be particularly advantageous in the treatment of plants since they are able to establish themselves intracellularly within plant cells along with exhibiting species and tissue independence (Cocking et al., In vitro Cellular & Developmental Biology Plant (2006) 42 (1). These properties, combined with their ability to travel throughout a range of plant tissues, make such strains better able to deliver the benefits to the target crop plants.
However, a wide range of strains of Gd exist and it has not yet been possible to provide a means for easily identifying strains which have these beneficial properties.
Furthermore, an important aspect of bio-fertiliser has been to provide an alternative to the chemical fertilisers in a nature friendly way to agricultural crop plants. However, it would be helpful to validate the effectiveness of any on-going treatment in field conditions, so that a farmer is able to determine what levels of nitrogen fertiliser, if any, are required to be supplied to enhance growth conditions.
The applicants have found specific advantageous strains of Gd contain a number of unique nucleic acid sequences that are not found in other Gd species, nor in any other species, including plant species. This means that the beneficial strain can be readily identified and gives rise to the provision of a reliable diagnostic test, useful in both monitoring of treatments in the fields and in research, for identifying related beneficial strains.
According to the present invention, there is provided a strain of Gluconacetobacter diazotrophicus (Gd) characterised by the presence of at least one nucleic acid sequence selected from SEQ ID NOS 1-10 or variants or paralogues thereof and/or the presence of a single plasmid of about 17566 bp in size.
Strains having these unique characteristics have been found to be particularly effective in intracellular colonization of plant cells resulting in beneficial nitrogen fixing. In particular, it has been found that use of a stain of the invention leads to yield enhancements in crops such as cereal crops like maize and wheat. Alternatively, similar yields can be achieved even with reduction in traditional nitrogen fertiliser applications.
Sequences of SEQ ID NO 1-10 (shown in attached Table 1) hereinafter, are present in the particular strain IMI504853 but do not appear in genomic analyses of other available strains.
Variants of SEQ ID NOs 1-10 will include allelic forms which are highly naturally occurring variants. They will have a high level of sequence identity, for example, at least 70%, 70%, for instance at least 71%, 75%, 79%, 81%, 84%, 87%, 90%, 93%, 95%, 96% or 98% identical to the basic sequence. Identity in this context may be determined using the BLASTP computer program with SEQ ID NO 2 or a fragment, in particular a fragment as described below, as the base sequence. The BLAST software is publicly available at blast.ncbi.nlm.nih.gov (accessible on 27 Jul. 2015).
In particular however the strain of the invention is characterized by the presence of at least one nucleic acid of SEQ ID NOS 1-10, suitably at least 3 different nucleic acid sequences of SEQ ID NOS 1-10, for example at least 5 or at least 8 different nucleic acid sequences of SEQ ID NOS 1-10, and in particular by the presence of all nucleic acid sequences of SEQ ID NOS 1-10.
Preferred strains may also be characterised by the presence of a single plasmid of about 17566 bp in size. The presence of a plasmid, in particular of this size, differs from a previously known strain of Gd, UAP5541, which has been reported as lacking in plasmids (Luis E. Fuentes-Ramièrez et al., FEMS Microbiology Ecology 29 (1999) 117-128). Furthermore, the size of the plasmid is smaller than that reported previously in respect of PAL5 strains containing a single plasmid (Giongo et al. Standards in Genomic Sciences, May 2010, Volume 2, Issue 3, pp 309-317 doi: 10.4056/sigs.972221).
The plasmid of strains of the invention may also be characterized in that it is restricted into two fragments by the restriction enzyme EcoRI, wherein the fragments are about 12 Kb and about 5.6 kb in size respectively. Furthermore, the plasmid lacks a number of key sequences which have been previously identified as being present in the plasmid of PAL5. These sequences are shown as SEQ ID Nos 65, 66, 67 and 68 in the attached sequence listing. Thus the absence of these particular sequences may provide a further characterizing feature of the strains of the invention.
A strain of the invention has been deposited with CABI in the UK under the Budapest Treaty with deposit accession number IMI 504958 (formerly IMI 504853).
Dot plot analysis of the plasmid of this strain was performed against the small plasmid (NC_010123; 16610 bp) from PalS DNA sequence analysis (M. Bertalan et al. BMC Genomics (2009) 10:450 DOI: 10.1186/1471-2164-10-450) using GEPARD software V 1.30 (Krusiek et al. Bioinformatics 2007; 23(8): 1026-8). Interestingly, no plot was produced when DNA sequences of the two plasmids were compared. This indicates that the homology is so low that no structural similarity could be established by the software; thus confirming that the plasmid is a single and unique plasmid.
For use in agriculture, the strains of the invention are suitably formulated into an agricultural composition.
Thus a further aspect of the invention comprises an agricultural composition comprising a strain as described above in combination with an agriculturally acceptable carrier. Generally the concentration of nitrogen-fixing bacteria that is present in the composition will vary depending upon factors such as the manner of administration, the type of plant or seed being treated and the particular strain of Gd used and the level of enhanced nitrogen-fixation required. Typically however, the compositions will comprise a solution containing from 1 to 1×109 bacteria per millilitre of composition, for example from 10-103 bacteria per millilitre of composition for instance from 50-200 bacteria per millilitre of composition such as 100 bacteria per millilitre of composition. Such a composition may be obtained by culturing the bacteria to a readily detectable level for example by examining the optical density and then diluting the solution accordingly.
The Gd may be the sole active component of the composition or it may be combined with additional agrochemically active components such as insecticides, fungicides or plant growth regulators, provided these are compatible with Gd.
The composition of the invention suitably comprises a solvent such as water although organic solvents, such as vegetable oils or hydrocarbons such as paraffin or kerosene oils may be used if required. Suitably any organic solvent is a vegetable oil such as soybean oil, sunflower oil, canola oil (oilseed rape oil), cottonseed oil, castor oil, linseed oil or palm oil or mixtures of these.
The composition may further comprise additives or excipients such as thickening agents, dispersants, diluents, humectants, solid carriers etc. as are known in the art.
In a particular embodiment, the composition further comprises a polysaccharide or an agriculturally acceptable surfactant or a combination of these. The applicants have found that such components may enhance the activity of the composition, as described in a co-pending British patent application. Suitable polysaccharides include hydrocolloid polysaccharides derived from plant, animal or microbial sources.
In particular, these include exudate gum polysaccharides such as gum Arabic, gum ghatti, gum karaya and gum tragacanth, cellulosic derivatives such as carboxymethylcellulose, methylcellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose or microcrystalline cellulose, starches and derivatives including, for instance corn starch, tapioca starch, potato starch, rice starch, wheat starch, and modified versions thereof such as pregelatinized starch, oxidized starch, ethylated starch, starch dextrins or maltodextrin, pectin, polysaccharides derived from seaweed such as agar, alginates, carrageenan, and fucellaran, seed gums such as guar gum and locust bean gum, polysaccharides derived from microbial fermentation such as xanthan gum and gellan gum, and nitrogen containing polysaccharides such as chitosan; or mixture of these.
In a particular embodiment, the polysaccharide is exudate gum polysaccharide such as gum Arabic, gum ghatti, gum karaya or gum tragacanth. A particular example of the polysaccharide is gum Arabic.
The amount of polysaccharide present in the composition may vary depending upon factors such as the manner of administration, the type of plant or seed being treated and the particular strain of Gd used and the level of enhanced nitrogen-fixation required. This will vary depending upon the various factors such as the particular polysaccharide used, the type of plant or seed being treated, the particular strain of nitrogen-fixing bacteria employed and the method of administration. However, typically, a composition comprising from 0.1 to 1% w/w, for example from 0.1 to 0.5% w/w such as about 0.3% w/w polysaccharide is used.
In a particular embodiment, the composition further comprises a surfactant or detergent including in particular a non-ionic detergent such as those sold under the trade name ‘Tween’®, for example Tween 80. Tween 80 is a non-ionic detergent; 70% composed of the fatty acid oleic acid and the remainder a combination of linoleic, palmitic and stearic acids. The pH of a 1% solution is in the range of from 5.5-7.2. It is widely used for emulsifying and dispersing substances in medicinal and food products. It has little or no activity as an anti-bacterial agent (Dawson et al. (1986) Data for Biochemical Research, 3rd ed., Oxford University Press (New York, N.Y.: 1986), p. 289). The amount of surfactant included vary depending upon the various factors such as the particular surfactant used, the type of seed being treated, the manner of administration, the type of plant or seed being treated and the particular strain of Gd used and the level of enhanced nitrogen-fixation required. However, typically, a composition comprising from 0.0005 to 0.2% v/v for example from 0.0005 to 0.15% v/v such as about 0.001% v/v.
Suitably a nutrient for the Gd is also included in the composition. Examples include a 3% w/v sucrose solution as described in EP-B-1422997.
Since by and large, all the components of the compositions are natural products, the environmental impact of the treatments of the invention is low and the compositions may satisfy regulatory requirements relatively easily.
In a particular embodiment, the formulation is applied as a seed coating as described above. In particular, the formulation is applied to seeds, either by spraying or by soaking and the seeds are then dried to form a residual coating comprising Gd thereon.
A further aspect of the invention provides a method for enhancing the nitrogen-fixing ability of a plant, said method comprising administering to the plant or to the environment thereof, a strain of Gd as described above, or an agricultural composition comprising it so that the Gd colonises plants and in particular enters plant cells (intracellular colonisation).
This may be achieved in a variety of ways. For example, the Gd may be administered to a growth medium of the plant, in particular on or after germination, using a method as described for example in EP-A-1714545. In this case, administration of in particular low levels for example from 1-100 bacteria per millilitre of inoculum to the growth media such as agar is applied to grasses, in for example on germination or shortly thereafter, for example up to 7 days thereafter.
Alternatively, the Gd may be applied to a seed in particular to the surface of a seed, for example in a pre-germination soak or, in a particular embodiment, as a seed coating. Alternatively, the one or more compositions may be applied to a growth medium on which the seeds are allowed to germinate. Such growth media include artificial media such as agar gels as well as soils or composts in which the seeds are about to be or have been sown.
In yet another embodiment, the Gd is applied to growing plants in and particular to a wound of the plant. This technique is described in the applicants copending International Patent Application No PCT/GB2015/052170. In this method, the nitrogen-fixing bacteria is administered to a wound of a growing plant. The wound may be a result of accidental or natural damage, whereupon the additional nitrogen availability may facilitate repair growth. However, in a particular embodiment, the wound is the result of damage caused by actions such as mowing (amenity grass), cutting (silage and hay crops), consumption by livestock (pasture grass) or by harvesting. Therefore, a preliminary step of inflicting ‘damage’ on the grass, in particular by mowing, cutting, or by harvesting may be carried out before administration of the nitrogen-fixing bacteria. The nitrogen-fixing bacteria is suitably applied within a relatively short time period of carrying out such actions, for instance, within 48 hours, for instance within 24 hours, such as within 10 hours and suitably within 1-2 hours of damage being inflicted on the plant.
Delivery of the bacteria is achieved by application of a suitable formulation to the wound area in particular in the form of a composition. The composition may be in the form of a liquid, gel, paste which may be applied directly or in diluted form, or it may be in the form of a solid composition such as a powder or granule composition that will be dissolved in liquid such as water before use. In solid compositions, the bacteria will generally be used in dried form, for example in freeze-dried form, which are reconstitutable on addition of water. However, the desiccation resistance of the present strains may mean that freeze-drying is not required.
In a particular embodiment, the composition is in a form suitable for spraying on the plants and thus will comprise a concentrate for dilution which may be in the form of a liquid or solid, in particular in the form of a liquid, or it may comprise a dilute aqueous composition that may be sprayed directly.
The amount of nitrogen-fixing bacteria that is administered in any particular case will vary depending upon factors such as the type of seed or plant being treated, the particular strain of nitrogen-fixing bacteria used, the level of germination enhancement required and the method of administration. Typically however, the seeds or the environment thereof such as the growth medium is inoculated with a solution containing from 1 to 1×109 bacteria per millilitre of inoculum, for example from 1-100 bacteria per millilitre of inoculum, for instance from 10-80 bacteria per millilitre of inoculum such as 50 bacteria per millilitre of inoculum. Such a solution may be obtained by culturing the bacteria to a readily detectable level for example by examining the optical density and then diluting the solution accordingly.
In a particular embodiment, the Gd is administered together or in combination with a strain of Terribacillus, as described in the applicants co-pending International patent application No. PCT/GB2015/052171. The applicants have found that such a strain may enhance the activity of the Gd. Suitable strains of Terribacillus include Terribacillus saccharophilus, Terribacillus halophilus, Terribacillus goriensis or Terribacillus aidingensis but in particular is a strain of Terribacillus saccharophilus. The Terribacillus is administered either separately or in admixture with the Gd. The Terribacillus may be in intimate admixture with the Gd, or it may be administered in a co-culture, or mixed culture form.
Suitable plants include leguminous and non-leguminous crops and ornamentals. The non-leguminous plant is preferably selected from the grass family Gramineae (includes rice [Oryza sativa], wheat [Triticum aestivum] and maize [Zea mays]). The non-leguminous plant may also be one selected from families such as: Solanaceae (includes tomato, potato and tobacco), Brassicaceae/Cruciferae (includes cabbages, turnips, oilseed rape and the model plant Arabidopsis thaliana), Malvaceae (includes cotton), Compositae/Asteraceae (includes sunflower and lettuce), Euphorbiaceae (includes cassava), Chenopodiaceae (includes sugar beet). The leguminous plant is preferably selected from the Leguminosae (includes soybean, clover, alfalfa, peas and other beans). Seeds treated may be of monocotylendous or dicotylenous plants but in particular are monocotylendous plants such as grasses, rice, wheat, barley, sorghum, millet, oats, rye and maize. In particular the seeds treated in accordance with the method of the invention are grasses such as Lolium perenne.
Other crops listed above may use the Gd to facilitate survival in non-optimal pH conditions as described above.
Once inoculated as described above, the Gd of the invention will colonise the plant cells and act symbiotically within the plant to enhance nitrogen-fixation.
Thus a further aspect of the invention provides a plant or seed which has been colonised by a strain of Gd as described above. In particular the Gd is located intracellularly in living plant cells.
The applicants have found that intracellular Gd will pass from generation to generation and that thus seeds and other progeny obtained from the seeds and plants of the invention will also comprise intracellular Gd. Such seed or progeny form yet a further aspect of the invention.
By enhancing nitrogen-fixation, plants may show enhanced properties, such as more rapid or improved growth characteristics and/or improved yield. In a further aspect, the invention provides a method for producing a plant product, said method comprising growing a plant colonised with Gd as described above, and obtaining the product therefrom.
In addition, the applicants have noted that certain plants colonised by nitrogen-fixing bacteria, in particular intracellularly colonised plants, show not only enhanced growth or yield characteristics, but also show an increased chlorophyll level as compared to plants without such intracellular bacteria. The plants which appear particularly to demonstrate this property are grasses including pasture, amenity or turf grasses. This is particularly advantageous in the context of such plants as high chlorophyll levels give rise to a better green colouration, which is highly desirable in an ornamental context.
Thus, in a further aspect, the invention provides a method for increasing chlorophyll in grasses, which method comprises growing grasses which comprise Gd as described above.
The grasses may include grasses such as pasture, amenity, turf or ornamental grasses, for example, Lolium spp, such as Lolium perenne, Lolium multiflorum, Lolium persicium, Agrostis spp. such as Agrostis castellana, Agrostis capillaris, Agrostis stoloniferia, Festuca spp such as Festuca rubra, Festuca ovina, Festuca longifolia, Festuca arundinacea, Poa spp such as Poa annua, Poa Pratensis and Poa trivialis, Paspalum vaginatum, Cynodon spp such as Cynodon dactylon, Zoysia spp such as Zoysia japonica, Zoysia tenuifolia, or Emerald Zoysia, Stenotaphrum secundatum, Buchloe dactyloides or Pennisetum clandesinium. Generally however, Lolium spp. and/or Festuca spp. form the basis of many amenity or turf grasses.
The Gd may be administered to the grasses using any of the techniques described above, but in particular, may be applied to the seeds of the grasses as a coating, or to wounds of the grass, inflicted after cutting.
Strains in accordance with the invention may be identified and/or monitored by use of a diagnostic kit comprising means to determine the presence in a sample of at least one nucleic acid sequence selected from SEQ ID NOS 1-10.
As discussed above, SEQ ID NOs 1-10 represent unique and novel sequences, which appear in a preferred sub-species or strain of Gd. Thus they provide a means for identifying these beneficial strains. In addition, they have been found to be amenable to detection using primers which do not cross-react with plant species.
Furthermore, since the strains can colonise intracellularly in the host plant cells, they are able to effectively travel throughout the plant. The kit of the invention can be used to provide an evaluation of colonisation by Gd post-germination at a young stage and check its efficiency. This will then allow the farmers to make an “informed decision” about the existence and extent of the colonisation and if required how much chemical based nitrogen fertiliser will be required to be applied. This extra level of security will provide ‘assurance’ to farmers that their crops are being well-tended, even when using nature and crop friendly fertiliser in the form of Gd.
In a particular embodiment, the kit may comprise means for determining the presence of more than one of the nucleic acid sequences of SEQ ID NOs 1-10, for example up to 10, such as up to 5, or up to 3 of said nucleic acid sequences of SEQ ID NOs 1-10. In this way, a reliable diagnostic kit would be provided which will ensure that the strain detected is the one which is similar or substantially similar to the beneficial strain. Similar strains would be detected even if one or more of the sequences differs for example as result of mutation.
Preferred strains appear to contain a plasmid, and so plasmid detection, for example by isolation using a commercially-available plasmid isolation kit, may provide further confirmation of the identification of a beneficial strain. In particular, any plasmid identified should be less than 27455 bp in size, for example about 17566 bp. The presence of a plasmid, in particular of this size, differs from a previously known strain of Gd, UAP5541, which has been reported as lacking in plasmids (Luis E. Fuentes-Ramièrez et al., FEMS Microbiology Ecology 29 (1999) 117-128). Furthermore, the size of the plasmid is smaller than that reported previously in respect of PAL5 strains containing a single plasmid.
The plasmid may be subject to cutting, in particular by means of an EcoRI restriction enzyme, to yield two fragments of about 12 kb and about 5.6 kb.
The diagnostic kit may further comprise means for determining the presence of at least one nucleic acid sequence which is characteristic of Gd species, for example 2, or 3 nucleic acid sequences which are characteristic of Gd species. In this way, the kit would provide confirmation that some Gd is present in the sample, thus confirming the accuracy of the test. If the sample is known to contain Gd, a positive result in this determination would act as a ‘control’ confirming that the test has been carried out effectively. Suitable specific strains will be sequences found in Gd species generally but not in other species, and in particular not in other microbial species or in at least some plants, in particular plants which may be targeted for Gd treatments.
Particular examples of such sequences are shown as SEQ ID NOS 11-13 in Table 2 hereinafter. In particular, these nucleic acid sequence which is used to detect Gd species have been found to be amendable to detection of Gd species present in a range of crops, without cross-reacting with plant species.
In addition, the kit may comprise means for detecting sequences which are not found in the strain of the invention, to provide a negative control. Examples of such sequences are shown as SEQ ID Nos 65-68. In a further embodiment, the kit comprises means for detecting the presence of a plant specific nucleic acid sequence, such as a chloroplast specific nucleic acid which amplifies universally from plant DNA. The inclusion of such means will act as a control when the kit is used in the context of detection of Gd within a plant species, as this means will produce a detectable signal, even in the absence of any Gd. If this signal fails, this would indicate failure in the test rather than necessarily that there is no Gd present. A particular chloroplast primer set which is available commercially from Thermo Scientific. Product as Phire Plant Direct PCR Master Mix, is based on the disclosure by Demesure B et al (1995) Molecular Ecology 4:129-131.
The means for detecting the presence of the nucleic acid sequences may take various forms as would be understood in the art.
Where the nucleic acids are genes which are expressed, the kit may comprise means for detecting the expressed proteins. Such means may include specific protein tests such as immunochemical analysis which utilise antibodies specific to the proteins to immobilise and/or detect the proteins, such as ELISA or RIA techniques, or immunoelectrophoretic methods such as Western blotting.
However, in a particular preferred embodiment, the kit of the invention comprises means for detecting specific nucleic acids themselves.
In particular, nucleic acids may be detected using any of the available techniques including nucleic acid binding assays and immunoassays using antibodies raised to haptenised forms of the nucleic acids. However, in a particular embodiment, the detection involves nucleic acid amplification reactions, and thus in particular, the kits will comprise one or more amplification primers which target the or each nucleic acid sequence being detected.
As would be understood by a skilled person, when detection of a sequence is carried out using an amplification reaction, it would not be necessary to amplify the entire sequence, but rather just a characteristic fragment of the entire sequence, for example a fragment of at least 10, and suitably at least 50 base pairs. Thus the size of the sequence that may be amplified would could be in the range of from 10-3070 base pairs, and suitably from 20-2000 base pairs, for example from 50-500 base pairs, such as from 100-300 base pairs. The size of the fragment will depend upon the nature of the detection reaction being used, but it should be sufficient to ensure that the product is characteristic of SEQ ID Nos 1-10 or variants as defined above, and so is not present in other sequences, in particular plant sequences. Where more than one sequence is amplified, they may be selected to be of differing sizes, so that they may be easily differentiated during detection, using techniques such as separation on the basis of size, or melting point analysis.
If required, the kit may further comprise one or more additional reagents necessary to carry out a nucleic acid amplification reaction. Thus it may include enzymes such as polymerases, salts such as magnesium or manganese salts, buffers and nucleotides as would be understood in the art.
The kits may, if required, include means for detecting the products of the amplification. Such means may include dyes or probes, in particular labelled probes that bind the target sequence intermediate the primers. Alternatively, the primers themselves may be labelled to facilitate detection.
Suitable nucleic amplification reactions include reactions that utilise thermal cycling such as the polymerase chain reaction (PCR) and ligase chain reaction (LCR) as well as isothermal amplification reactions such as nucleic acid sequence based amplification (NASBA), strand displacement amplification (SDA), transcription mediated amplification (TMA), loop-mediated isothermal amplification (LAMP) and rolling circle amplification, 3SR, ramification amplification (as described by Zhang et al., Molecular Diagnosis (2001) 6 No 2, p 141-150), recombinase polymerase amplification (available from TwistDx) and others. In a particular embodiment, the nucleic acid amplification is a PCR, and may be a quantitative PCR (QPCR) to provide information regarding the extent of colonisation.
In an alternative embodiment, the amplification is LAMP reaction. LAMP assays utilise at least four and suitably six primers which are designed to target six different regions of the target sequence. There will always be two outer primers (F3 and B3) and two inner primers (FIP and BIP). Optionally, in addition there are two loop primers (FLoop and BLoop). The use of the Loop primers usually reduces the amplification time and increases the specificity of the assay. FIP and BIP primers consist of F2, complementary to the F2c region of the template sequence, and F1c, identical to the F1 region of the template. Four main features need to be considered in order to guarantee a successful LAMP primer design: the melting temperature of the primers (Tm), given 55-65° C. for F3, FIP, BIP and B3 primers and ≥65° C. for FLoop and BLoop; a GC content of 50-60% in the primer sequences; the absence of secondary structures formation and stability at the ends of each primers; and finally the distance between primer regions. Examples of suitable LAMP primer sets are disclosed hereinafter.
The presence of the products of amplification reactions may be determined using any available technology. Thus they may include techniques where products are separated on a gel on the basis of size and/or charge and detected such as agarose gel electrophoresis. Alternatively, they may be detected in situ, using for example using intercalating dyes or labelled probes or primers. The detection of amplification products using a wide variety of signalling and detection systems is known. Many of these systems can be operated in ‘real-time’, allowing the progress of amplification to be monitored as it progresses, allowing for quantification of the product. Many such systems utilise labels and in particular fluorescent labels that are associated with elements such as primers and probes used in the amplification system and which rely on fluorescent energy transfer (FET) as a basis for signalling. A particular form of such fluorescent energy transfer is fluorescent resonance energy transfer or Forster resonance energy transfer (FRET) for signal generation.
A major example of such a process used commercially is the TaqMan® process, in which a dual-labelled probe, carrying both a first label comprising a fluorescent energy donor molecule or reporter and a second label comprising a fluorescent energy acceptor molecule or quencher, is included in a PCR system. When bound to the probe, these molecules interact so that the fluorescent signal from the donor molecule is quenched by the acceptor. During an amplification reaction however, the probe binds to the target sequence and is digested as the polymerase extends primers used in the PCR. Digestion of the probe leads to separation of the donor and acceptor molecules, so that they no longer interact. In this way, the quenching effect of the acceptor is eliminated, thus modifying emissions from the molecule. This change in emission can be monitored and related to the progress of the amplification reaction.
Where more than one nucleic acid sequence is detected, the kit may comprise components sufficient to carry out multiple separate amplification reactions, such as individual sets of primers. Preferably however the kit is set up to carry out a multiplex reaction, where multiple targets may be detected in a single reaction. In this case, where the detection is done using gel electrophoresis, the primers are suitably selected so that each amplified product has a significantly different size or charge so that they may be readily separated and identified on an agarose gel, or by melting point analysis using a signalling reagent such as a DNA intercalating dye.
Alternatively, where the detection system includes labels, any labels provided for example on primers or probes, will provide a different and distinguishable signal from other primer sets, for example on the basis of the wavelength of the emitted signal and/or the fact that the product has a different melting point or annealing temperature, which may be distinguished by carrying out a melting point analysis of products.
Suitable amplification primers, in particular for PCR amplification, together with the approximate size of the products they generate are selected from those set out in Table 3 below:
TABLE 3
SEQ
SEQ
Product
ID
Forward
ID
Reverse
size
A
14
TGAAATTGACGCCCGTTGGA
15
CACGCCGGGAAAGAGGATTC
472 bp
B
16
GGCAACGCGGTTTCTACGAA
17
CGTTAGCCGGGGTTGTCAGA
489 bp
C
18
TCGTTGCCACTTTCCGAGGG
19
GTCGATTGTGTGCAGCGTCA
268 bp
A
D
20
CACCGATCTTGTGCGTTTCG
21
CGGCAATGCTCCATACCCAC
522 bp
E
22
CACCGGAAAGAGTGGCAGGA
23
AACCGGGTCACTTGCGTCAT
783 bp
F
24
AGCCATCGGAGTCACATCGG
25
GGAAACCTCGAAACCCTGCG
1129 bp
G
26
TCAGGGCAATCACTAGCCGG
27
TCGAGCAGCCGTTTCATCCA
1118 bp
H
28
TGATGCGCTTGTTCGTGACG
29
CGTTCGCCCTTGTCGTCATG
478 bp
I
30
GGGCCATCCGTTACCTGCTT
31
TGACACACCCGCTCCGAAAT
1102 bp
J
32
GCATTTGCGGTAAGTCATCC
33
GGATCCCGATTTGCAAGCCA
814 bp
CA
K
34
TGTCGGGTCGGGAACTCAAG
35
CGGGTTCTCGCTGATGACCT
464 bp
L
36
TCCCGCCTGCATCTGAAGAC
37
CAGCGATGCCAGCCAATACC
1098 bp
M
38
GTTCGTCGCGTCTGATGCAG
39
ACCTGGGCATTGTTGGTGGA
1045 bp
Primer sets represented by SEQ ID NOS 14-33 have been found to act as useful strain-specific primers for beneficial strains of Gd, while primer sets represented by SEQ ID NOS 34-39 act as useful Gd species-specific primers.
The kits may be used in methods for determining the presence in a sample of a strain of Gluconacetobacter diazotrophicus (Gd) able to intracellularly colonise plant cells, said method comprising detecting in said sample at least one nucleic acid sequence selected from SEQ ID NOS 1-10.
Suitably up to 10, for example up to 5 such as about 3 of said nucleic acid sequences of SEQ ID NOs 1-10 are detected.
The method may further comprise detecting at least one nucleic acid which is characteristic of Gd species, as described above, such as a nucleic acid sequence of SEQ ID NOS 11-13. Again, more than one such species specific nucleic acid sequence may be detected if required.
In addition, the method may further comprise detecting a plant specific nucleic acid sequence, which may be characteristic of the particular Gd colonised plant being examined or may be universally present in plants, such as a chloroplast specific nucleic acid sequence, as a control for the reaction.
Various methods of detection may be used in the method, as described above, but in particular, the method comprises a nucleic acid amplification reaction, such as the polymerase chain reaction (PCR).
Suitable primers are as described above.
The sample which may be used in the method of the invention may be any sample that contains or is suspected of containing a strain of Gd. This may include cultures or laboratory samples, which may contain the desired strain of Gd. Alternatively, they may comprise plant samples, including leaf, stem, or root samples, from which nucleic acid has been released, for example by causing cell lysis, for example using mechanical, chemical or sonic means. In particular, the sample is from a plant to which a strain of Gluconacetobacter diazotrophicus (Gd) has previously been applied. In this way, the successful colonisation of the plant by Gd can be confirmed.
Typically, such tests will be carried out in a laboratory, although mobile testing, for example, in field conditions, may be carried out if suitable equipment, such as mobile PCR machines, are available, or if detection of targets in particular protein targets, using techniques such as ELISAs, which may be carried out on lateral flow devices are employed.
The invention will now be particularly described by way of example with reference to the accompanying figures which are described as follows:
However, it will be apparent to one skilled in the art that the specific details are not required in order to practice the invention. The following descriptions of specific embodiments of the present invention are presented for purposes of illustration and description. They are not intended to be exhaustive of or to limit the invention to the precise forms disclosed. Many modifications and variations are possible in view of the above teachings. The embodiments are shown and described in order to best explain the principles of the invention and its practical applications, to thereby enable others skilled in the art to best utilize the invention and various embodiments with various modifications as are suited to the particular use contemplated.
Identification of Unique Sequences
IMI504853, a Gd strain derived from passaging UAP5541, which was found to have particularly beneficial plant colonisation properties was isolated and the full genome sequenced. A comparison was made against the publically available genome of the type strain (PAL5; sequenced by JGI, USA [Genbank sequence accession CP001189]) using standard methods.
Surprisingly, a large number of differences were noted in the genome, and in particular, a number of genes were identified which are present in the genome of IMI504853 but not PAL5.
Many of these genes were annotated with an associated function. The unique genes with annotations were further checked for uniqueness across all the genomes sequenced to date using the NCBI's web-based BLAST tool.
Analysis of the BLAST result narrowed the list to 20 unique genes not present in any genome. These unique genes appeared to be “strain-specific” for IMI504853.
Also, five sets were found to be unique to the Gd species and will hereafter be referred to as “species-specific” (i.e. present in IMI 504853, Pa15 and other Gd strains but in no other species).
Thus these sequence differences appear to characterise the strain and can be used to design a diagnostic kit for IMI504853 and similar strains.
PCR Validation
A set of 25 primer sets were designed based upon the sequences identified in the analysis of the genome. The specificity of these 25 primer sets (20 designed to be strain-specific and 5 designed to be species-specific) were first tested by carrying out a conventional PCR reaction using genomic DNA of IMI504853 and PAL5. The results with IMI504853 are illustrated in
All 5 species-specific primers reacted as expected.
Further, testing of strain- and species-specific primers was done against two other strains of Gd, one originally isolated in India (IMI 502398) and the other from Mauritius (IMI 502399), as well as a revived 2001 culture of UAP5541 strain (stored in glycerol at −80° C.), using the method described above. The data was in agreement with the 16 strain specific primers and 4 species specific primer sets as one of the species-specific primer sets produced a higher molecular weight band. This was a surprise result.
The sensitivity of detection of all 25 primer sets (20 strain-specific and 5 species-specific) was checked using serial dilutions of bacterial broth cultures. It was found that 24 of these sets produced very high levels of detection (requiring 1-10 bacterial cells).
Further, these 25 primers were then checked for cross-reactivity with several target plant species and varieties using DNA extracted in-house. The primers were tested in a PCR reaction using DNA extracted from plants of the following species: maize, wheat (var. Willow), quinoa, rice (var. Valencia), barley (var. Chapeaux), potato, Arabidopsis (var. Columbia), oilseed rape (vars. Ability and Extrovert) and a range of grasses (vars. Aberglyn, Dickens, J Premier Wicket, and Twystar). The method for isolating nucleic acids from plant tissues involved the mechanical maceration of leaf material followed by a modified CTAB extraction (Doyle and Doyle, 1987 Phytochem. Bull., 19: 11-15). Briefly, cellular membranes were disrupted using SDS and CTAB to release their contents, and cellular proteins were degraded or denatured using proteinase K and β-mercaptoethanol. The extraction buffer also contained PVPP to remove plant polyphenols, EDTA to chelate metal ions, sodium chloride to solubilise nucleic acid structures, as well as TRIS HCl to stabilise the buffer pH. RNA molecules were degraded using RNase A treatment. Following the removal of insoluble cellular debris using chloroform:isoamyl mix (24:1), deoxynucleic acids were precipitated in ethanol using sodium acetate, washed using diluted ethanol, and resuspended in molecular grade water.
Illustrative results are shown in
At the same time, the sensitivity of primers were tested by co-inoculating PCR reactions containing 100 ng of the above mentioned plant genomes with six-fold serially diluted genomic DNA from Gd, starting from 1 ng. It was found that the sensitivity of the PCR system was generally unaffected by the presence of plant genome and routine detection was established from a minimum of 1 picogram of Gd DNA.
Illustrative results are shown in
Of the strain-specific primer sets, only 10 produced results which were of (1) high specificity, (2) high sensitivity, and (3) produced no cross-reactions with plant DNA and these are represented in Table 3 above as primer sets A-J. Similarly only three of the selected species-specific primer sets were found to be specific and sensitive enough for use and these are shown as primer sets K-M in Table 3 respectively. In addition, the size of the products obtained using these primers is shown in Table 3 and illustrated in
LAMP Assay
A series of LAMP primers were designed to amplify regions of SEQ ID NOS 6, 7 and 9 and are shown in Table 4 below as follows:
TABLE 4
SEQ
ID
NO
Sequence
Type
40
CTCAGGAAGACCGAATTGATTA
F3
41
GCGAAACGTCTGATTGAAC
B3
42
CGGATAACCACTGGTGCTCCGACTCGCCTCACTCTACT
FIP
43
TCCACGAATCTCACGAAGCACCCCGACCTTATCTCCCAT
BIP
44
GCCAGGCGTGTACATATAACTA
FL
45
CGGAATACCTAGTTGGAACACT
BL
46
TCAAGATCGATGCACCTATTC
F3
47
AACAGACAGTTCTGGTAGGA
B3
48
CGCATCTCCAGATCGGCAGGTCGTCCAGTCGATCATG
FIP
49
ACATCTGTCCACGGCATTGGTGGCTGGCTTATGAGTCT
BIP
50
GAGAAGTCCTCTGCTTCGG
FL
51
CGGCGGTTGAGAAGATGT
BL
52
GGAAGACATCAACGAAGCA
F3
53
TTGACAGTTGCATAGTCCG
B3
54
ATACGGCTCGTCATGTCGCGGTGATGGATAATCTCAGCC
FIP
55
CAGTGGCCGAACCTGGAAGCGCTGATATAAGCCTGAAGAT
BIP
56
ATTGCACCGCGTTGATG
FL
57
GCGTAACGGTCACAAGGA
BL
SEQ ID NOS 40-45 were designed to amplify SEQ ID NO 6 above, SEQ ID NOS 46-51 were designed to amplify SEQ ID NO 7 above, and SEQ ID NOS 52-57 were designed to amplify SEQ ID NO 9 above.
These primers were obtained and tested in a LAMP assay on samples comprising pure Gd DNA that had been isolated using a modified CTAB methodology from bacteria grown in liquid culture.
In addition, DNAs from a range of plant pathogenic bacteria and fungi was tested for amplification in LAMP by the primer sets. These included Bacillus subtilis, Lactobacillus, Fructobacillus, Pseudomonas spp., Agrobacterium spp., a range of phytoplasmas and various fungi including species from the Fusarium, Penicillium and Aspergillus genera.
Real-time LAMP was carried out on a Genie II instrument (OptiGene), and 1 μl of sample was added to a 24 μl reaction mix containing 15 μl Isothermal Master Mix ISO-001 (OptiGene), 200 nM of each external primer (F3 and B3), 2 μM of each internal primer (FIP and BIP) and 1 μM of loops primer (FLoop and BLoop). RT-LAMP reaction consisted of 30 minutes of isothermal amplification at 63° C. To evaluate the annealing temperature of the products, reactions were then subjected to a slow annealing step from 95 to 68° C. (0.05° C./s) with fluorescence monitoring.
Negative reaction controls, consisting of water, were also used.
Of the three sets of primers tested in LAMP, the third primer set specific for SEQ ID NO 9 gave amplification in nine and a half minutes with an anneal at 89.2° C. (see
All sets of primers that gave the positive Gd amplification were specific for the bacterium and did not amplify from DNA of any of the other bacterial and fungal DNAs they were tested on. They are therefore all suitable as primer sets to be used for detection of the Gd bacterium.
Detecting Gd on Plant Samples Using LAMP
To validate the primers on rapidly extracted DNA from contaminated seed, a series of experiments were set up in which seed of two plant species, tomato and wheat, were spiked on the surface with Gd DNA. The samples were then put through the 2-minute DNA extraction technique in which the samples are placed in plastic tubes containing steel beads and TE buffer and shaken vigorously for 2 minutes. Two microliters of the solution was then placed in the LAMP reaction as described in Example 4 using the primer set comprising SEQ ID NOs 52 to 57 to test for amplification of the Gd DNA from these samples.
The results showed that the Gd DNA is detectable when put through these assays, against a background of plant DNA.
In order confirm that any samples that tested negative for Gd supported LAMP amplification (i.e. they do not contain inhibitors of LAMP reactions), the cytochrome-oxidase gene (COX) primers (Tomlinson et al., 2012 Journal of Virological Methods, 191: 148-154.), which amplify DNA from the host plant, were used as controls for false negatives on all samples.
QPCR Determination
A range of QPCR reactions were carried out on samples comprising known quantities of DNA from Gd (IMI504853) and also from a range of crop species including maize, barley and wheat genomic DNA.
QPCR reaction mixtures were prepared to a volume of 20 μL volume per reaction. In the case of Gd DNA alone, these consisted of 10 μL iTaq™ Universal SYBR Green® Supermix (2×) (Bio-Rad), 1 μL each of forward and reverse primers (final concentration of 10 μmol), 7 μL SDW (sterile distilled water) and 1 μL DNA template at the required concentration.
Primers used in this case were as set out in Table 5.
TABLE 5
SEQ
ID
NO
Sequence
Type
58
AGGAGGCTCTTTCTTTGGAAGC
Forward
59
AAGTGCCCCTGTTATCGTACAC
Reverse
60
TGGGTCATCGGTTCTGATTTCC
Forward
61
TAGTTTGATGTCGGGTGCTGAG
Reverse
62
GCGAATACCGGTCTTTTTACGC
Forward
63
ATGCAAGCTCCGGATTGAGAG
Reverse
The primer set represented by SEQ ID NOs 58 and 59 (designated P5) was aimed at amplifying a 149 base pair region of SEQ ID NO 3, the primer set represented by SEQ ID NOS 60 and 61 (designated P8) was designed to amplify a 104 base pair region of SEQ ID NO 6 above, and the primer pair represented by SEQ ID NO 62 and 63 (designated P17) was designed to amplify a 130 base pair region of SEQ ID NO 10 above.
Thermocycling was carried out using a CFX96 Touch™ Real-Time PCR Detection System from Bio-rad. Initial denaturation was performed at 95° C. for 3 minutes; amplification was performed using 40 cycles of denaturation at 95° C. for 5 seconds followed by 60° C. for 30 seconds (plate read post each amplification).
All of the primer sets amplified Gd DNA with good efficiency as set out in Table 6, which shows the average Cq values of three replicates of the amplification, and quantitatively as illustrated by
TABLE 6
P5 (SEQ
P8 (SEQ
P17 (SEQ
Log
ID NOs
ID Nos
ID NOs 62 +
Dilutions
58 + 59)
60 + 61)
63)
ng/μl
−1
19.23
19.68
19.96
12
−2
22.75
22.55
23.39
1.2
−3
26.19
26.10
26.78
0.12
−4
30.23
29.97
30.75
0.012
−5
33.64
32.85
33.96
0.0012
−6
36.15
36.26
37.04
0.00012
−7
NA
NA
NA
Slope
−3.4659
−3.3613
−3.4594
% Efficiency
94.32
98.38
94.57
The quantitative amplification was carried out in the presence of genomic plant DNA in order to determine whether there was any cross reactivity. It was found that whilst there was cross reactivity with some plants species, the primer pairs P5 showed no cross-reactivity to wheat and barley genomes, P8 showed no cross-reactivity to wheat barley and maize and P17 showed no cross-reactivity to wheat and maize genomes making these potentially suitable primer sets for detecting Gd in crop species.
To ensure that primer efficiency and robustness would be maintained in the presence of plant genomic DNA, the above QPCR examples above were repeated but in this case, the composition was varied in that 6 μL SDW (sterile distilled water) was used together with 1 μL relevant Gd dilution DNA template and 1 μL plant genomic DNA template. For instance, Gd DNA (92 ng/μl) was serially diluted from 10−1 to 10−7 with either wheat DNA (70.6 ng/μl) or maize DNA (111 ng/μl) and amplification reactions run as described above.
Representative results are shown in
TABLE 7
Gd + Plant DNA QPCR Std. curve
Cq Value from QPCR run
Log
P5 (Seq ID
P17 (Seq ID
ng/μl in
dilutions
3)_Wheat
10)_Maize
reaction
−1
21.47
21.76
9.2
−2
24.56
25.11
9.2
−3
27.69
28.13
0.92
−4
31.38
32.08
0.092
−5
34.89
35.32
0.0092
−6
37.55
37.80
0.00092
−7
N/A
N/A
0.000092
AzGd DNA
24.20
25.00
(0.01)
Plant DNA
N/A
NA
NTC
NA
NA
Slope
−3.2887
−3.2794
% Efficiency
101.41
101.81
It appears that the primers will maintain efficiency in the presence of plant genomes and thus may form the basis of a detection kit.
Results were confirmed by carrying out melt analysis post amplification the denaturation curve (Melt curve) analysis was performed from 60° C. to 95° C. with 0.5° C. increment 5 seconds/step followed by plate read after each increment.
Representative examples of the results are shown in
Plasmid Detection
Plasmid DNA extraction from Gd (IMI504853) was performed using Qiagen mini prep kit (Cat. No. 69104). The low copy number plasmid extraction protocol was followed using 5 ml and 10 ml 48 hour bacterial culture. The extracted plasmid was run on 1% agarose gel flanked by a 1 kb ladder (
Alongside the plasmid DNA, genomic DNA of Gd (IMI504853) was also included on lane-1. The results, shown in
The plasmid DNA was sequenced and a primer was designed using Primer3 (Untergasser et al. (2012) Primer3—new capabilities and interfaces. Nucleic Acids Research 40(15):e115; Koressaar and Remm (2007) Enhancements and modifications of primer design program Primer3 Bioinformatics 23(10):1289-91) to cover the start and end sites of linear sequence data (P_End_Fw—CCAAATCTCTGGAACGGGTA (SEQ ID NO 64). Sangar sequencing was performed using this primer (SEQ ID NO 64) and the sequenced data was aligned to confirm the plasmid sequence was complete.
Since plasmid DNA in its natural form is circular and can form secondary and tertiary structures, this may impact on the accuracy of size measurements using agarose gels. To confirm the results and also validate the sequencing of the plasmid DNA, a restriction map of plasmid was studied using NEBcutter. The restriction digestion will linearize the plasmid providing only a single conformational structure. Also, the restriction enzyme selection is done after studying the sequence, thus allowing the plasmid sequence to be validated as well. In case of IMI504853 plasmid DNA, the NEB-cutter showed the restriction enzyme EcoRI to digest the plasmid DNA at 3864-9461 bp and 9462-3863 bp producing a DNA fragment of 5598 bp and 11968 bp. Both the size can be studied using a 1 Kb ladder available in the lab, removing the limitation of the reference ladder's maximum size detection as well.
Therefore, restriction digestion was performed on IMI504853 plasmid using double cutter EcoRI (Fisher, cat no—10819360) as per supplier's protocol. Post restriction digestion the products were run on 1% agarose gel until the bands were resolved and imaged. IMI504853 plasmid DNA when restricted with EcoRI produced two fragments (1. ˜12 Kb and 2. ˜5.6 Kb) of DNA of predicted size (
This validated the sequencing data in terms of both size and sequence. It may further provide an identification test or a confirmatory test in relation to a kit used in the identification of strains of the invention.
Illustration of Activity of IMI504853
A field trial was designed to test Gd (IMI504853) as a bio-fertilizer using wheat (cultivar Mulika). Two plots of Gd treated and control (untreated) respectively where planted. Post germination the young wheat seedlings at 10-12 day of growth were sampled and tested for Gd presence using the primer G (seq ID 26 & 27) representing the DNA seq ID 7. The Gd presence was detected when PCR was resolved on a 1% agarose gel with respective negative and positive controls (
The measurement of chlorophyll content i.e. “greenness” using a SPAD meter has been shown to correlate with over all plant health and crop yield. The crop at growth stage 35 and 61 were checked for its chlorophyll content using SPAD was found to be statistically significantly (P=0.001) in Gd treated plots when compared to control plots (
Yield Benefits of use of IMI504853
Forage maize seed untreated and treated with a formulation comprising IMI504853 at a concentration of about 105-107 cfu/ml was sown at two different locations, and fertilised at different proportions of the recommended rate of nitrogen fertiliser, ranging from 0 to 175 Kg ha−1 for each particular variety, region and availability of soil nitrogen. Yield results indicated an overall potential reduction in nitrogen fertiliser of between 40-95% without suffering any yield penalty. Average yield benefits across N levels led to an increase in yield of between 7% and 21%. Thus at full recommended N fertiliser rates IMI504853 treated crops could provide a yield benefit up to 1 t/ha in maize.
In another trial, spring wheat seed, either untreated or treated with a formulation comprising IMI504853 at a concentration of about 105-107 cfu/ml was sown in Spring. The crop was fertilised at different proportions of the recommended rate of nitrogen fertilizer ranging from 0 to 125 Kg ha−1 based on variety, region and availability of soil nitrogen. Across all fertilizer levels, IMI504853 treated crops showed an average yield increase of 15%, but at zero nitrogen fertilizer and full nitrogen fertilizer this increase was 20% and 10% respectively. The results indicate that for the IMI504853 treated crop, it is possible to reduce N fertiliser application by up to 85% and still achieve the same yield as a fully fertilised crop.
TABLE 1
SEQ ID 1
Glutathione S-
ATGACAAAATTATACTATTCTCCCGGCGCTTGCTCTTTGGCAGGGCATATTTTGCTCGAAGAGTTGGGAAGACC
transferase (EC
ATATGAGTTGAAATTGACGCCCGTTGGAGACGAAGGCACGGGAAGTGAAGAGTTTCTAAAAATAAACCCGCGAG
2.5.1.18)
GAAGGGTGCCTGTTTTAATTGATGGTGCGGAAATAATTACCGAAAGCCCCGCAATCTTATTTTATTTATCGAGT
TCATTTTCAGACGGAAATTTCTGGCCAAAATCAGTTTTGGAGCAAGCCCGCTGCTGGGAATGGTTTAACTGGTT
ATCGAGCAATGTACACTCGGTTGCCTATGGGCAGGTGTGGCGACCAGGACGGTTCATTGATGATGAGCGTCAGT
GGAATAATGTTATTTCAAAAGGGAAAAATAACCTTCATGAATTTAGTGATGTAATAGAAAATAATATCTCCGGG
AAAACGTGGTGTGTGGGTGAATCGTATTCATGCGTTGATCCGTATTTGTTTGTTTTTTATTCTTGGGGGAAAGC
CATCGGATTGGATATGGAATCCTCTTTCCCGGCGTGGTCGCGTCATGCAGCGCGGATGCTGGAGCGGTTGGCCG
TTCAAAACGCTTTACGGCAAGAAGGTTTGATCTCGTAA
SEQ ID 2
O-
TTGGATGCCTCTCGTTTTCCTTGCGGAGTCATCATGACCATTCCTCTCTTTCGTCCGCAATTCACACCGCAGAT
methyltransferase
TCAACGTGCGCTTGATCGCCTTTATTCCGAGACACTCTCGCAAGATCCAGCGATACGCCAATTGGCGCAAGCCA
(EC 2.1.1.-)
AAGGACTGACACATGACGGGCAACGCGGTTTCTACGAAGCCATGAAAGATGCCAGACTACCCGTTACGCCAGAG
TTCGGCGCCCTGCTCTATATTCTGGCACGCAGCACCAGAGCCCAACATATCATCGAATTCGGCACGTCCTTCGG
TGTTTCAACATTATTTCTCGCAGCGGCTTTACGCGACAATGGCGGGGGCCGACTGGTGACCTCGGAACTTATCT
CAGACAAAGCAGAAAGGGCTTCCGCCAATCTGCGGGAGGCAGGACTGGCAGACCTCGTAGACATTCGCATCGGA
GATGCCCGCGCCACGTTATCGCGTGATCTTCCTGAGTCGATCGATCTGATCCTGCTGGATGCGACTAAAGGACT
CTACCTCGATCTCTTACTCCTGCTGGAACCTGCATTACGAAAAGGTGGCCTGGTGATCAGCGATCGCGCCGATC
TCGATGGTGACGACGGCGGTCGCGCAGCAGCCTACCTTACCTATCTGACAACCCCGGCTAACGGATATCGCATC
GCCGGCATCACTACACAGGCGTTGGGACAAACCTTCGCTCACGATGTGGCGGTGCGCACCTGA
SEQ ID 3
Transcriptional
GTGGGAATAGCCACGCTCTACCAATACTTTGAGAACAAGGAGAGCGTTGTCGCGGCACTTAGTCGTCGGGTACG
regulator, TetR
GGAAACACTGCTCCATGATGTTGCGTCATTACTCGAAACCGCTTGTTCGTTGCCACTTTCCGAGGGTGTGCGCT
family
GTCTGGTCGTCGCTGCCGTGAAGGCGGACAAGAGCCGTCCATCGCTTACGGTCCGGCTTGATCGGTTGGAGGAG
GCTCTTTCTTTGGAAGCGGATCATCTGCTGGTAGCGGCTGAGCTTTGCACGGTTGTTGCGTCGTTCCTCAAGTG
CCAGGGAATTATTCAGGAGAACACTGCAAAAATTCTGGCAGATGATCTGTGTACGATAACAGGGGCACTTATTG
ACGCTGCACACAATCGACAGATACCTATCGATGACTTGCTAATTGACCGTATTACGCGAAGGCTGGTCGCGATT
ATTCAGAGCGCGCTTTAA
SEQ ID 4
RNA polymerase
GTGGGACAGCCGGACAAATATTTCGAGCTTTTCGCGATACATCGCACCGATCTTGTGCGTTTCGCCAGAGGTAT
ECF-type sigma
CATGAGAGATGATAGTCTGGCGGAAGATGTTGTACAGGATGCTTTTCTGCGGCTGACTACTGTAACAGTGGCAC
factor::RNA
AGGACCGCGTTCTTTCGGATCCTCTGAATTACGTTTACCGCATTATTCGGAATCTGGCCTTTGACCGTTATCGA
polymerase ECF-
CGACGGCAATTCGAGGCCGGATTGTTTGACCATGGGGTAGATAGTTCTTCCGAAACAATCGAAGCGGATGCCCC
type sigma
TACACCGGAAGGTGAGGCTTCAGGGAAATCCGACATGCGGGCAATGCGCGCCGCTATGGCGGAACTGCCAGAAC
factor
GGACGTGCGTCGCATTGGAAATGCATCTGTTCGACGGACGAAAGCTACGGGAAATAGCGGCTCATTTAGGTGTT
TCTATTGGGATGGCCCACTCCCTTGTCGCAGTGGGTATGGAGCATTGCCGCAAACGTCTTTCCACACCTGAAAC
CTGA
SEQ ID 5
FecR family
GTGAGCGAAGACTTCAATCCAACAACGGCGGTTGAGTGGAAAATAGCCCTTTCAGAAGAGCCTGACGATTCTGT
protein,
GCTCAGAGAACGCTTTGAAGCATGGCTTGCTGCCGCAGAGGATCACCGGAAAGAGTGGCAGGAACTTACGCAGG
COG:Fe2+-
GACTTGAGAATTTCCGCCAGATTGGCCCGCTTTATCGTGAGAAATGGGTGCCTTCATCAAGTGGGGCACAAAAT
dicitrate
ACTGCGTCAAAACAAGGTAGGCTCAAAGGAAGACCTGCTAATTTTGTTAGGTTTTCAGTTGCTGCATTTGCGGC
sensor, membrane
TGCTGCTGCCGTTACATTGGTATGGTCCTCTGACCTTCTGCTTCGATTACAGGCCGATTACGCCACAGGCTCGG
component;
CAGAAACGCGAACAGTCAGTCTCCCCGATGGTAGTGAATTGACCCTCGCGCCGCGAAGTGCGGTAAAAATGTCT
TACTCTGTAGAGAAACGGGATATTCGTCTTTTAAAGGGAGAGGCGCTCTTCACGGTTCGACATGATATGGCGCG
ACCTTTTGAGGTCCACACAGACAAATTCACCGTAACGGACATCGGAACTATTTTTGACGTCAGAATGTCTCAGG
GCGAGGAAGAAGTCTCTGTCCGGGAAGGAGAGGTCCGGGTGCAGGATGTTTCCGGTGGATTTCATAATCTCGAT
GCCGGAACGTGGGAGCGGATTAGAACTGTAGGCAATGGAGTGAGCGTCACTCATGGGAGCGGCTCTCCGGAAGA
TGTGGGCGCATGGTCAGCGGGGCAAATTATTGCCAAGGAAAACAGCGTGTCCAGCGTCGTGGAAAGGCTTAGGC
CCTACTACCGGGGGGTTGTTGTCCTTTATGGTTCTTCCTTTGGGGAGAAGTCACTCACTGGTGTTTATGACGCA
AGTGACCCGGTTGGCGCATTTCGGGCGATCGCAGCCGCGCATCATGCTCAGATGCATCAGGTTTCGCCATGGCT
GACAATATTGGCCGCACCGTAG
SEQ ID 6
Ferrichrome-iron
ATGAAGGGTGCGGTTGCATTGCATTCGCAATTGTGGCGGCTCATACGAATGGGAACGGATAAGGTGATGACGAT
receptor
TGATGATAGAATGAAGCGGTGTGGGCGGCAGGTGGCGTGGCTTATCGCGCTGGGTAGTACGACGTTTCTGAATG
CCGCTGTGACGAAAAGCTATGGTGCAGAACCTTCCCAAAGTGCTCGGGCCGTCAGATCATTTTCCATTCCGGCC
CAATCTCTTGAPGATGGTCTCGCAAGGTTCGGACAGCAAAGTGGGTGGCAGGTTTCTGTTGACGGAAATCTTGC
AAAATCTCTGACAACGCACGGTGTTAGCGGTACGATGACATCTGCTCAGGCCCTCAATGCGATCCTGTCCGGGA
CTGGCCTGACATACACGATCAGGGGTGGCCGAACCGTCGTGCTGACGAAAGCAGTAGCCAACATCACGCTTGGT
CCGGTCCGTGTCGGAGGAACCCTCGCGCGTCAGGATCCAACAGGGCCGGGTGTCGGCTACTTCGCCGAAAACAC
AATGGTTGGTACAAAGACGGATACGCCCATCACGGAAATACCGAACTCAGTCTACGTCGTGACCAAGCAGTTGA
TGACCGATCAGCAGCCGCAGAATATCCTACAGGCTTTGCGTTACACTCCCGGCATCTACTCTGAAGCCGGAGGA
ACGACAAATCGCGGATCTGCCCAGAATGACAACATGGGCATTTATCAGCGTGGATTTCTCTCGAGCCAGTTCGT
GGATGGGTTGATGACGAATTCGTATGCCGCCGCCGAGCCAAGCTTTCTGGACCGTATCGAGGCGCTCAACGGTC
CAGCATCGGTGATGTATGGCCAGACGACACCCGGAGGAATGGTCGGTATGAGCCTGAAGAAACCCACCGAAACG
CCGCTGCATCAGGTTTCGCTAGGCTTCGGAAGCTGGGGACGGTACGAGGCAACGTTCGATGTCAGCGATAAGAT
CACGCAGTCCGGTAATCTGCGCTATCGTATTGCAGCCATCGGAGTCACATCGGGCACTCAGGAAGACCGAATTG
ATTATCATCGGGTGGGTGTACTTCCTTCAATCACGTGGGATATCGATCCCAAGACTCGCCTCACTCTACTTGGT
AGTTATATGTACACGCCTGGCTCAGGGAGCACCAGTGGTTATCCGGTCCTCGGGACTCTTATTCACAATTCGGA
AATTCCACGAATCTCACGAAGCACATTTATCGGAATACCTAGTTGGAACACTATGGGAGATAAGGTCGGGATGT
TCGAATATCAATTTAGTCATAAATTTAATAAATTTATTGAGTTCAATCAGACGTTTCGCGTAGAGAATTCCAAC
GTTCATGAGTCAAATATCACCGATGTAACACCTGTAGATGTTGAAGGAAAATGGACATATTTTTATCCTTGGAA
ACAAAATTATGAAAACACAACTGAGGTACTTGATACTCGCTTAGGGGGGCGGTTTCTAACTGGTCCTGTACAAC
ATACATGGGTCATCGGTTCTGATTTCCGCAATTATGACTATCATTATACTGAGCTCATCGACGACGGTGCGACA
ATCGTTGTGCCCACTCAGCACCCGACATCAAACTATTCCCCATGTATAAGTTTAACCTCCGCGAAGTGTGACGC
CTTCGCGGGAATAAACCCAGACTATAACTCGTTTCAGGAGGGCGTGTATTTTCAGGACCAGATAAAATGGCAGC
GCCTGTCCGTTCTCTTGGGTGGACGCCAAGATTGGGTTAATTCATCTAATAAAAATTACAGTGTAACGAACTTT
TATGGAAACGTCAGCACCCGCGTTAATAACACTGCTCCACACCCTCAATCGGCCTTCACCTGGAGAGCTGGTAT
AATCTATAATTTTGACTTTGGGCTTGCCCCGTACTTCAGTTACGCAACATCCTTTGTGCCACAAGGAGGTACGG
ATTGGCAGGGTAAGATTTTCGCGCCTTTGAGCGGAAAGCAACTCGAAGCCGGGTTGAAGTATAAAGTTCCAAAC
GAAGATATCCTCATAACGGCATCAGCATTCCGAATTGATGAAGACCACTATCTTATCAGTGATCTTGTTCACAC
GGGCTTTAGCAGTGACGCGGGAACGGTACGCTCGCAGGGTTTCGAGGTTTCCGCCAGTGCGAACATTACCAAAA
ACCTCAAACTTGTCGCCTCTTACACATATGAGGATGTGCGGTTCAGAAAGAACAATTTGGCCGTAAATTCGGTC
GATCCCGTCACGCTAACATATGGAGCAAAGGTAAGCGAGAATGGAAAATTCGTTCCTCGAGTTCCTCGGAATAT
GTTTAATATGTTTCTTGATTACACCTTCCACGACGCCCCATTGAAGGGTCTCGGCTTTAATGGAGGAATTCGCT
ACACCGGTTTTACCTATGCGGACTATGTGGAGTCTTACAAAACGCCGGCGTATTATCTGTTTGACATTGGCGCA
CACTATGATTTTGAGGAAATAATCCCTTCTCTCAAAGGTCTGCGTGCCCAGTTGGCAATCTCAAATTTGGCCAA
TAAATATTATATTACTTCGTGCAATACCGCCATATGTACTCTCGGTTATGCTCGAAAGTTTTACGGTAACGTGA
CGTATAGCTGGTGA
SEQ ID 7
Reverse
GTGACGCCCGAATTGCTCCTCTCCAAGGTGCGGCTGCTGCGGTCGCCCAATGACGACGGCGCGTTCTTCGACCT
transcriptase
AGTCGGCAGTGTTCTTAATTGGTCCTGGGAGGAAAGAGACGAACGTCAATTCGCCCGCTTCAAGCAGCGCGCGG
family protein
GCATCCCTGAGTTCGATGGCGTCGCCCTTCCACAGGGTTTGGTTGCAGCTGGCTTCTTCTCGAACATCGTGCTG
CTTGATTTCGATCGGATCGTCATCGGACAGATTGGGAGAGAAGTTACAAACGGAGTGTGGCTCCGGGACGCCTG
CCGGTACGTCGACGACATTAGACTGACCATAACAACTGCACCAGGTATTGACCCAAGAGAAGCTCAGGCGCGTG
TAATGGCGTGGCTTGGGCAACTCCTCACGGGGAGCTGTCCGGGCTTGGAATTCTCCCCGGAGAAGACGTCAACT
GCGTCGGTTGGAGGCGAGCAGATGCCGCTGGTTCGCCAATCCCGAAAGATGGAGCGCATCCAGACCGCGATTTC
CGGCGGCTTCGATGCCAGTGGTGGCGAGGAGGTGATCCACGCGATCGAAGCCCTCGTCCGATCCCAGCTAACGA
TCAACAGCGTCGAAGAGTCGCCTACCCCTCCCGGCTTGAGAGCGGTACCCGATGTCAAAGACGAGACAGTCGGT
CGTTTCGCTGCTGGTCGGTTCAGAAAAACCTTTCGTTCATTGAGGCCACTACTCGATGATCGACCTTACATGGA
GATTGCTGAATTCGGGGAGGAGACGTTCCGGCGCACCCGACTTTCGCAATCGGAGCTTGACGAGGAAGCACGCG
CATTTGCGCTAATCCTAGTCGAACGGTGGATACTCGATCCTTCGAATGTGCGGCTGCTGCGCGTCGCACTCGAC
CTCTGGCCGTCCCGCCAACTCCTCAAGGAAGTACTGAAACTCTTTGAGCCCTATCTTGTCGGGAAGATCAGGGC
AATCACTAGCCGGCAAGTTGCATACTACTGCCTCGCCGAGATATTTCGAGCAGGGGCGACCGAGACGGGCTTCA
TTGACGATCCAGAGTGCCTTCCCGCTGCCGTCGATCTCGCCGGTTATAGATCTCTGCTTCTGGAGGCCGCAGTA
CGAGTGGCCCGGGGCGAAGCCGAACGTGTCCCGTGGTATCTCGCGCAACAAGCACTGCTTTACATTGCGGTCCA
CGATCCCCGGGCTATCCAAGATCGAGGAATTTCAAAGACCAATCGATCCTATTGGCGCCTCGTCTCATTTCTGA
AAGGCGAACGCGACGTCTCTTCAGATCGCGAATTCGCAGTAGCCGCGGTGGTGAGCCGCAGGTCGTTCCTTTCG
AATGATCAGGCCGTGGATCTCGTCGGTCGGATGCTCACGCCAGAGCGGTTCGCCGAGGTGGCCGCGCGCGACAT
AGAATTCGCCCGCGATCTCTTTCGCGCCGTCGACCGACACCTCACCGTTCCGGCAGGCATTGCCGAGGACTTGG
GGGTCGCCGAATGGTCCATGTCAGAGGAAATGAGCTCTCTGCAAAGCTATATCCAAGGCAAAGGGCCTCTGAAT
CCGCTACGCAATGAGATCGGCGTACTCAGTTTTGCAGAGAAATTCATCTCCCATCTCCAAGAAGGAAATTTGCC
GGAAGTCGTGACGCCGTCGACGACGCAGATAGCGGTACAGCAAGTGGGCAAATATGTCCGCGTCGAACGGGTGA
TCTTCAGATCGGCCCAGACAACGCCGACTTACCGGTCTATTTATACTGCTCCCAGATGGGCGCCGGAATCTCAA
CGCTGGCGCTTTCAGCTCGGTTATTTACTTCGCTTCATTCTTACTGCCAGAATAGACTTCAGCCTTCCAGTTAG
GCCGCCATCGTGGAAGGAAGGTAAACACATCTATCGGCCTACCAGAAGTCACTGGTTTCAGCGGCAATACGGCT
TCTATAATGGGCATGAGGCCTTCGGGGACGATTGGCTACCCATTTCGCAGTTCACTCAGGATCTTCTCTTCGAT
CTGCTCACCTGGCCCGGCTGCCGCACAAGTAGCCCGGATGTCGATCAGTTGTCCCTGGATGAAACGGCTGCTCG
AATCCGCGCAGCTCTCGTAGAAGCCACCGCTGCGATTGGCCCGGCTACAGGAACCCTGATGCTCAAGATCGATG
CACCTATTCCAGGTACCACATCGAAGGGGCGCCCGCTTCGGGCCTGCGTCGTCCAGTCGATCATGCCCGAAGCA
GAGGACTTCTCGGCTGCCGATCTGGAGATGCGCTCGCCGGCCCTTCGACGAAAGCACCGCAAACATCTGTCCAC
GGCATTGGCGGCGGTTGAGAAGATGTTGGATCTTCGCGAGACTCATAAGCCAGCCAGCAAGCGTCTCGACTGGC
TCATCCTACCAGAACTGTCTGTTCACCCGGATGACGTTGCCACCCACCTCGTGCCGTTCGCGCGAGCGTTCAAG
ACCGCGATCCTGGTCGGCATGGCCTACGAACAAGTCGTCACGGGAGAGCCGCTGATCAACTCGGCCCTCTGGAT
TATCCCGAGGATGGTGCGGGGCATGGGCCTACAGACGGTGATCAGACGGCAGGGAAAACAGCACCTCTCTCCGA
TGGAACAGAAGTACGTCAAACCGGTCGAACTGATCACCGGATTCCGCCCGTGCCAGTGGCTGGTGGGGTACGAA
TGGTCGAACAATCCGGCCAAAGACGCACTTTGGCTCACCGCGTCCATCTGCTACGATGCAACAGACCTGAAGCT
GGCGAGCGATCTTCGTGATCGCTCAGACGTGTTTGCGATCCCAGCCCTGAATCTCGACGTCGGCACCTTCGATC
AGATGGCGCAGGCGCTGCATTATCATATGTTCCAACTCGTGCTGATCGCGAACAACGGAGCTTATGGGGGCAGC
AATGCTCACGTTCCCAAGGGGGAGGCCTATCAACGCCAAGTGTTCCATACCCATGGCCAGCCCCAGGCTACAAT
TTCCTTTTTCGAGATCGACGATATCGAGGGCATGAAGCAGAGACACAAGCTCGGCGCTGGGAAGGAAGGCGGGT
GGAAATATCCACCTGCCGGCTGTCAAGTCTGA
SEQ ID 8
DNA topology
TTGATGCGCTTGTTCGTGACGGGGCCAACTGGCAGTGGAAAATCAACGCTGGCTGCAAAGTTGGCTCAAAGGGC
modulation
AGCTATACCACTGTTCCCGCTCGATGAAATTCATTGGGTTCGCCATCTCTCCGGGGATTGGCGGCGCGATCCTG
protein
TTGAACGCCTGTCTATGCTCGGAGAGATTGTACAGCTCGATGCCTGGGTCATCGAAGGCGTGCAGTTCAAATGG
ACTGATATAGCGATAGAACGAGCAGACTGGATCGTCGTCCTCGATCCACCACGTTGGCGGAACATCGCTCGTAT
CCTGCGCCGTTTCGTCAATCGCCGATGCTTTTCTGGGGCGGGGCACCGTGGAACGGTAAAGGCTCTATTGGAGG
AGATGCGTTGGTCAGCCGACTACTATGGTCATGAACGCGGTATGCTGTTCGAGAAGATTGGACAATCGCCAGAC
AAGCTCATCGTCGTACATGACGACAAGGGCGAACGCGCTTTGACCGAGGCTGTATTCGCGACTGCGTGA
SEQ ID 9
Cycloisomal-
ATGGCATATTGGATCAGGCTCTCGCTGGCCGTGTGGCCGCCCGATCAGCAACGTTGTAGCGAAGGCCGCGTAAT
tooligosaccharide
GCGCCGCTATCTTTTCACAACCATTCTCTCGCTCTTACCGTCCCTTGCGGCGGCGGCATCCCTCCAAGGTCCGA
glucano-
TTGTTTCGCATGTGCGGGATGATCGGGCTTTCTACCAGGCAGGCAATGTCGCGATGATTTCCGTGGAACTGACC
transferase
CCACTAGCCGCTTGGACGGGAGGCCATGTGGATCTAGCGATATGTTCGCGTGGGCAAGTCGTGGGCACGATTCA
precursor
GAGCCAAGCGGTCACCAGCATGGTGGCTGGGGCGGACCAGACACTTCACTATCCCGTCACCGTTCCCAGTCTCC
(EC 2.4.1.-)
ATGCTCATGGGTATCAGTTGGCTATCGCGGCCCTGAACAATGGGGACAGCGGGACAGCGTCCTGTACCGGGACA
GGCAGCACTTCCACGTCGCCGGCCGATGTGGCGTCAGGCGGCATCAACGTGGCCGCGAATGCCTGGGAAGACAT
CAACGAAGCATGGGTCGACGCGCCGACGCTCGGCAACGTCTCCGCGGCCCGGGTGATGGATAATCTCAGCCAGT
ATCACATCAACGCGGTGCAATTTTACGACGTGCTGTGGCGACATGACGAGCCGTATTCATCCGCCCCGCAGTGG
CCGAACCTGGAAGGCGTAACGGTCACAAGGACCAATCTTCAGGCTTATATCAGCGCGGCGCATAGCCGCGGCAT
GGTGGCGCTCGCCTATAATCTCTGGAACGGAGCCTGGGCGGACTATGCAACTGTCAATCCGAAGGTCACGGCGG
CAATGGGGCTCTATGCTTCGTCCGGACAGAAACACCAACTGACCAACGGCGGGGGCTGGCTGTCCTGGGGGTGG
TCGACCGACCATATTGCTGAAATGAACCCGTTCAATGGCGACTGGGCCAGATGGCTAACCAGCCAGATCCAGAA
GACCATGTGGAATTTAGGATTCGACGCCGCGCATCTGGATACGTTGGGTGACCCTGGTGGTCAGCAATATGACG
GCGAGGGCCATCCGTTACCTGCTTTAGGAACGATTCTGGCAGACTTTGCGAATAATGTACAGGCTCAGACCGGG
GCACCAACTGACATCAACGCCGTTTCGGGTTGGAATACCACCGACCTTTACCTACGCGGTACGGGACCCAACCT
GTATATCGAACCCCATCCCGAATTCGGAAACACGCCGGGCTACGATGATTCCCGAAGCTTATGGGACATCAAAC
AGAAATATACGTCGCGCCCGCTGATGACGGCGTTTTATCCGCAGCAGGTCCAGAGCGGTTCGCTGAGCACGTCC
TTTGCCGTCAAGGGTGAGAGTGTGAAGGTTTGCGACCCGACGTTAAAATCCGGATGCATAGCCAATAACCTCGG
CATTGAGTTGTTGCTCGGCCAGATTGCGCTCAATGGAGGCTCCAATATTACTCTTGGTGATTTTGATCATCTGA
TACCGGGGCCATATTTCCCCCGTCCGACCCTTAAGATCGACGGTCCATTGCAGCAATATCTGGCGGATTACTAC
AACTGGTGGGTCGGAATGCGCGATCTGCTGCGTGTCGGCGTCATCTCATCCAATGAGAGGGAGTCCATCCGGAA
TGGAAACGGAGCCAGTATCGGCCAACCTTATGCCCAACCGGGAACCGTCTACTATCATCCCCTGATACGCGCTG
GCATCGCTGGTGAATTGGCGCTCACAAACATGATCGGGTTGCATTATAATCGGATTGACGACCCTGACGGCAAA
AACAATCCGACCCCGGTGAACAACCTGTCGATCGAGATGGAATTCTGGGAAAGAAGCACACCGGGGGCATTGTA
CTATAGCGCGCCCGACATCAACCACGGCTTCCCACAGCCCCTCACCTATAGGCTGAACGGAAACGGTAGCGTGA
TGTTTACGCTACCGACTCTCAAGACGGTGGCGCTTGTTTGGCTGGAAGGCACCAATTTCACCACTACGACCGAT
TACACGATCGGTACGGCGCAGGATGTGAGGGGTGGCACAGCAAACTTCTGGACGAACGGCAGCGGAGAGGATGC
TACCGGATATCGTGGCTGCTGTGGTCGCTCCGCACGCTGGGACAGCATCGATTTCGGAGCGGGTGTGTCAACGC
TAACGATGGTAACCCGAAGCCAACTCGGCGGACTGGTCGAATTTCGCCTGGATGCACCTGATGGACCAGTCATC
GCCCGTAATTATGTTCCTGCGTCTAGCGCCACGACAACAACCACTCAATTACGCAGGCCAGTATTCGGGACACA
TACCGTCTTCGCTAAAATTCCTGGTCGCGAGATTACGCTGATATCCTGGAAGCCATAA
SEQ ID 10
Methyltransferase
ATGATGGCTAACGACAATACCACTGAGGTGGTTGGTGCATTTGCGGTAAGTCATCCCAACTTGGCGCAAGGTTT
(EC 2.1.1.-)
TACTTTTAGTAACAGCAGTCAACTAGATACGATTGCTTCTACTATTCATAAAAGCGGTTTGGAGACTTATGAAG
CTCCGACAACTAATATAATTATCGAACTGATCAGGAGTTCGTCTGGTCTTATTTTAGATGTGGGAGCGAATACC
GGTCTTTTTACGCTAGTCGCCGCAGCAGCCAACCCCCTGATCCGCGTCTGCTCTTTTGAGCCGCTTGCGAGTAT
TCGTGAACTTCTCAAGAGCAATATTGCTCTCAATCCGGAGCTTGCATCACGTATCGCTGTCGAGCCTGTCGGGT
TATCGAATGAACGGGGCACTTTCACTTTTTACGAAACGATCAACAATCGTGGCTTTGTCACGACGAGTTCATCG
CTTGAAAAAGCACATGCAGAGCGAATCGGCGATTTGTACGTCGAGCGCACTATCGAGACCCGGACACTTGATGA
ATTCGGAGAAACGCTCGGGAATGCGAGCGTTCCGTTCGTCAAAATTGACGTTGAGGGACATGAGCATGCCGTTA
TCTCCGGTGGCCGCCACTTTATCGCCAAGCACCGCCCTTTTCTTACTCTCGAAGTCCTGAGAGAGGCTAACACT
TTGAGTCTGGACCAGTTGGTGACCGAGTCCAACTACCTTGCCCTGGCAATGGCACCCGACGAATTGCGGCAGTG
CGAGCGTTTACGGTTTCATGACGACGCCTGGAATCATCTTTTGGTCCCCGCCGAAAAAGCGGAACGGCTATTTT
CGCTCTGCCGCCGACTTGGCTTGCAAATCGGGATCCGCTGA
TABLE 2
SEQ ID 11
Transcriptional
ATGTCGAATTCCGAGCGCCCAATGCGCGATTTGTCGGACCTGGCAAAAAACCGACAAATAGAGCCGATGGTTAT
repressor;
CAGGCTACGAGAAGTAGTGGATCGGACCGGAGGCGCGAAAGCTGTGGCCGCACGCACGGACATCCCTCTCAGCA
asserted_pathway:
CACTTTCAGGTTACCTGTCGGGTCGGGAACTCAAGCTTTCCGTCGCGCGCAAGATCACGGAAGCCTGCGGTGTC
PF01381<br>
AGTCTTGACTGGCTTGCGGCAGGAGAGGACGGACCTGCGGCCCGGGAATTCGGCAATGCCCGGCAGGCGGGTCC
Peptidase S24-
CGAGTCGGTCGAGTTTCTGAATTACGACGTCATTCTCTCCGCCCACCAGGGCGTCGACGGGGATAGTTCTTATA
like::PF00717
TCGAAACGAGAATATCGATACCGCGGGATTTTCTCCCTTTGTCCATTCAGTCCAATACGGACAACATTTCGGCC
GTCACGGCGAAATGCGACAGCATGAATCCGATCATAGACGATGGAGACATTCTTTTAATAAGAACGGATGTGCA
TACGCTCACAAGTGGCAGCATCTATGCCCTGCGGGTAGAAAACACCCTTCTGGTCAGGCGTCTGATCCTCAAGA
CCAACGGCAACGTCCAGGTCATCAGCGAGAACCCGCGTTACCCGACCGAGGAACTGAACGCCGAGGACGTTCGC
AGGATGGTCCAGGACGACGGCTTTCCGGCCAGGATCATCGGCCGGGTCATCTGGCGCGCCGGTAGCCTGATTCC
ATAG
SEQ ID 12
outer membrane
ATGCGCATCGTCCTCTTGCCCTGCCTCGTCGCGACCTCAATAAGTATGTTGGCGGTTTCCGCATCCTATGCTTG
heme receptor
GGCGGACAATAGCCCGTCGCCCCCCAGGACGAACAAACAGGCCAAATCGCGGCCGTTACATGCGCAGGGGACGC
GCAAAGCGGGCAGCGCCATCACCAGCCAGGATGAAGCGGTGGCTGTCGTGGGAACACGTGAGACATCGCATGGG
ATGGAGCAGAGCGTTACCCGTGCGACGATGGACAAGTTCGTGGCGGGGACCAGTCCCCTGCAGATTCTGTCGGC
CACGACACCGGGTGTCAATTTTGCCTCGGACGACCCGTTCGGCCTGGATACATGGGCGAACACATTTTATATTC
GCGGCTATTCCCAAAGCCAGTTGGGCATCACCCTGGACGGTATCCCGCTGGGCGATGCCCAGTTCATCAATTCC
AACGGCCTCGATATCAATCAGGCGATCATCCAGAACAATATCGGTCGCGTCGACATGTCGCAGGGTGGCGGTGC
GCTCGATGTCATGTCCGTCACCAACCTGGGTGGCGCGCTGCAATATTATTCACTCGATCCGCGCGACAAGGCTG
GTGGAGACATTTCACAGACGTTCGGCAGCAACCAGACCTATCGCACGTACGTCAGCGCCCAGAGCGGCAAGCTC
AATCCCAGCGGGACGAAGTTCTATGCGTCGTACGCGCGCACCGATGCCGGGAAATGGAAAGGCGCCGGGGACCA
GTTCGAACAGCAGGCGAATTTCAAGATCGTACAGCCGCTCGGGCGTTACGGAAAACTGTCCGGATTCTTCAATT
ATTCCGAATTCGACCAGTATAATTACAGCGATTTGAGCCTGGAAATCATCCAGAAGCTCGGCCGGAACGTGGAT
TATTTCTATCCGAACTACAAAGCCGCGTATCAGGCTGCCGAGGGGATCTATCCCGCAGGCTATGCCAAGGTCGG
AGATGCCATGGACGTCTCCTATTACGATGGTGGCCAGGACCAGCGGAATTATCTTTCCGGCATCACGTCCACGA
TCGACCTGACGTCCCGCCTGCATCTGAAGACGGTGCTGTACGACCAGCAATCGGCGGGGGACTACGAATGGACC
AACCCCTATGTGTCGTCGCCCTCGGGCGCGCCCATGATCCAGCAGGTCGGGCACACATCGATGACGCGCGTGGG
CGGGATTGGCGCGGTGCAGTACCAGATCGCCAATCATTCGCTTGAAACCGGCGTCTGGTACGAAAACAACGGAT
ATAGCTGGGCGCAACGGTACTACAACCAGCCGCTTCTGGGGGAGGGTACGCCCCGAAGCGCCACCGGACCGTAC
AACGATCCGTTCGCCACCGCATACGCCATGACCTTCAATACCAACAGTTTTCAATATTACCTGGAAGATTCCTA
CCGTATCTTGAAGACGCTGCGGGTGCACGCGGGCTTCAAATCCATGCTGACGACGACGTCGGGCGGCGCATCCT
ATAACAATCCCGTCTATACGGGCCAGGACACCCTGCCCAGTGGCAGCCTGACCACCGCCAGCGCCTTCCTGCCG
CATGTCAGCATCAACTGGAATTTCCTGCCCCGGAACGAACTGTTTTTCGACTTCGCGGAGAACATGCGCGCATT
CACCTATAATACATGGCAGAGCGGGAATGCATGGGGAGTCAATGAGATGCCCCAGAACCTGAAGCCCGAGACCA
CCTTCAATTACGAGGTCGGTTATCGATATAATTCCCGCTTCGTCACGGGCCTCGTCAATCTGTATCATATCGAT
TACAGGAACCGGCTGGCCACCATCACCACCGGCAGCCTGGTGAACGCCCACAATACCTATATCAACGTGGGGAA
CATGGCGATCTGGGGTGCCGATGCCGGCGTGACGGTGCGCCCGCTGCCGGGCCTCGAGATCTTCAACAGCGCCA
GCTACAACAAATCCACCTATGGGCAGGATGTATCCAGCGGCGGGGTAAATTATCCCATCAGCGGCAAGCAGGAG
GCCGGCTATCCGCAATGGATGTACAAGGCCAACGTCTCGTACAGGTATGGCAACGCGAAGGTCAACTTCAACGT
CAACTATATGGGAAAGCGATACATCTCGTACATGAACGACGCCGCCGTGAACGGGTATTGGCTGGCATCGCTGT
CGGCGACGTATATCTTCAAAACCATTCCCCATCTCTCTCAGCTTGAATTCAATTTCGGCGTCTACAACCTGTTC
AACCAGGAATATATCGGCGGCATCGGCGGGTTCTCACTGTCCGGTGACACGCAGCAACTCTTTGCCGGCGCGCC
ACGCCAGTTCTTCGGTACGCTGCACGCACGGTTCTAG
SEQ ID 13
Levansucrase
GTGACGGCGCGGTCGTGGTTGCTCTGCAATCTGAAGAGTTTCCTTCAGGAGGATGGAATGGCGCATGTACGCCG
AAAAGTAGCCACGCTGAATATGGCGTTGGCCGGGTCCCTGCTCATGGTGCTGGGCGCGCAAAGTGCGCTGGCGC
AAGGGAATTTCAGCCGGCAGGAAGCCGCGCGCATGGCGCACCGTCCGGGTGTGATGCCTCGTGGCGGCCCGCTC
TTCCCCGGGCGGTCGCTGGCCGGGGTGCCGGGCTTCCCGCTGCCCAGCATTCATACGCAGCAGGCGTATGACCC
GCAGTCGGACTTTACCGCCCGCTGGACACGTGCCGACGCATTGCAGATCAAGGCGCATTCGGATGCGACGGTCG
CGGCCGGGCAGAATTCCCTGCCGGCGCAACTGACCATGCCGAACATCCCGGCGGACTTCCCGGTGATCAATCCG
GATGTCTGGGTCTGGGATACCTGGACCCTGATCGACAAGCACGCCGATCAGTTCAGCTATAACGGCTGGGAAGT
CATTTTCTGCCTGACGGCCGACCCCAATGCCGGATACGGTTTCGACGACCGCCACGTGCATGCCCGCATCGGCT
TCTTCTATCGTCGCGCGGGTATTCCCGCCAGCCGGCGGCCGGTGAATGGCGGCTGGACCTATGGCGGCCATCTC
TTCCCCGACGGAGCCAGCGCGCAGGTCTACGCCGGCCAGACCTACACGAACCAGGCGGAATGGTCCGGTTCGTC
GCGTCTGATGCAGATACATGGCAATACCGTATCGGTCTTCTATACCGACGTGGCGTTCAACCGTGACGCCAACG
CCAACAACATCACCCCGCCGCAGGCCATCATCACCCAGACCCTGGGGCGGATCCACGCCGACTTCAACCATGTC
TGGTTCACGGGCTTCACCGCCCACACGCCGCTGCTGCAGCCCGACGGCGTGCTGTATCAGAACGGTGCGCAGAA
CGAATTCTTCAATTTCCGCGATCCGTTCACCTTCGAGGACCCGAAGCATCCCGGCGTGAACTACATGGTGTTCG
AGGGCAATACCGCGGGCCAGCGTGGCGTCGCCAACTGCACCGAGGCCGATCTGGGCTTCCGCCCGAACGATCCC
AATGCGGAAACCCTGCAGGAAGTCCTGGATAGCGGGGCCTATTACCAGAAGGCCAATATCGGCCTGGCCATCGC
CACGGATTCGACCCTGTCGAAATGGAAGTTCCTGTCGCCGCTGATTTCGGCCAACTGCGTCAATGACCAGACCG
AACGGCCGCAGGTGTACCTCCATAACGGAAAATACTATATCTTCACCATCAGCCACCGCACGACCTTCGCGGCC
GGTGTCGATGGACCGGACGGCGTCTACGGCTTCGTGGGTGACGGCATCCGCAGTGACTTCCAGCCGATGAACTA
TGGCAGCGGCCTGACGATGGGCAATCCGACCGACCTCAACACGGCGGCAGGCACGGATTTCGATCCCAGCCCGG
ACCAGAACCCGCGGGCCTTCCAGTCCTATTCGCACTACGTCATGCCGGGGGGACTGGTTGAATCGTTCATCGAC
ACGGTGGAAAACCGTCGCGGGGGTACCCTGGCGCCCACGGTCCGGGTGCGCATCGCCCAGAACGCGTCCGCGGT
CGACCTGCGGTACGGCAATGGCGGCCTGGGCGGCTATGGCGATATTCCGGCCAACCGCGCGGACGTGAACATCG
CCGGCTTCATCCAGGATCTGTTCGGCCAGCCCACGTCGGGTCTGGCGGCGCAGGCGTCCACCAACAATGCCCAG
GTGCTGGCGCAGGTTCGCCAATTCCTGAACCAGTAA
Patel, Dhaval, Dent, David, Devine, Gary
| Patent | Priority | Assignee | Title |
| 11618720, | Jul 28 2014 | AZOTIC TECHNOLOGIES LTD. | Plant inoculation method |
| Patent | Priority | Assignee | Title |
| 8304215, | Mar 03 2010 | SAMSUNG DISPLAY CO , LTD | Gluconacetobacter strain having cellulose producing activity |
| 20020142917, | |||
| 20110225679, | |||
| 20120015805, | |||
| 20120309000, | |||
| 20150101373, | |||
| 20160355445, | |||
| 20200048666, | |||
| EP1130115, | |||
| EP1714545, | |||
| WO3020014, | |||
| WO2010022517, | |||
| WO2011144741, | |||
| WO2016016629, | |||
| WO2016016630, | |||
| WO2017017439, | |||
| WO2017017440, |
| Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
| Jul 27 2016 | Azotic Technologies LTD | (assignment on the face of the patent) | / | |||
| Feb 13 2018 | DENT, DAVID | Azotic Technologies LTD | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 046431 | /0736 | |
| Feb 13 2018 | DEVINE, GARY | Azotic Technologies LTD | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 046431 | /0736 |
| Date | Maintenance Fee Events |
| Jan 24 2018 | BIG: Entity status set to Undiscounted (note the period is included in the code). |
| Feb 01 2018 | SMAL: Entity status set to Small. |
| Apr 03 2024 | M2551: Payment of Maintenance Fee, 4th Yr, Small Entity. |
| Date | Maintenance Schedule |
| Oct 06 2023 | 4 years fee payment window open |
| Apr 06 2024 | 6 months grace period start (w surcharge) |
| Oct 06 2024 | patent expiry (for year 4) |
| Oct 06 2026 | 2 years to revive unintentionally abandoned end. (for year 4) |
| Oct 06 2027 | 8 years fee payment window open |
| Apr 06 2028 | 6 months grace period start (w surcharge) |
| Oct 06 2028 | patent expiry (for year 8) |
| Oct 06 2030 | 2 years to revive unintentionally abandoned end. (for year 8) |
| Oct 06 2031 | 12 years fee payment window open |
| Apr 06 2032 | 6 months grace period start (w surcharge) |
| Oct 06 2032 | patent expiry (for year 12) |
| Oct 06 2034 | 2 years to revive unintentionally abandoned end. (for year 12) |